Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Proietto M, Crippa M, Damiani C, Pasquale V, Sacco E, Vanoni M, Gilardi M (2023) Tumor heterogeneity: preclinical models, emerging technologies, and future applications
If the peptide isn't dissolving, be patient
for instance, limited bloodbrain barrier permeability hampers glioblastoma treatment
A key therapeutic advantage lies in their dual capacity to sensitize tumors to chemotherapy while protecting healthy tissues from damage
- Should reapply every 2-4 hours
US$ 28.49
US$ 26.87
US$ 29.62
US$ 22.52
US$ 21.32
US$ 21.01
US$ 22.70
US$ 22.68
